Physiol. Genomics Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 32: 343-351, 2008. First published December 11, 2007; doi:10.1152/physiolgenomics.00067.2007
1094-8341/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
32/3/343    most recent
00067.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Liu, Y.
Right arrow Articles by Liang, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, Y.
Right arrow Articles by Liang, M.
Received 22 March 2007; accepted in final form 26 November 2007.
Physiological Genomics 32:343-351 (2008)
1094-8341/08 $8.00 © 2008 American Physiological Society

Suppression of 11β-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis

Yong Liu1, Frank Park2,3, Jennifer L. Pietrusz1, Guangfu Jia2,3, Ravinder J. Singh4, Brian C. Netzel4 and Mingyu Liang1

1 Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin
2 Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
3 Department of Kidney Disease Center, Medical College of Wisconsin, Milwaukee, Wisconsin
4 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota

11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1), which regulates the local level of glucocorticoids, has been suggested to be involved in the development of obesity. A definitive functional role for 11β-HSD1 in adipogenesis, however, remains to be established. We developed 3T3-L1 cell lines stably transfected with a small hairpin RNA (shRNA) targeting 11β-HSD1. A shRNA containing two nucleotide substitutions was used as a control. Silencing of 11β-HSD1 substantially attenuated the accumulation of lipid droplets and the expression of adipogenesis marker genes, which was induced by a mixture containing either corticosterone or dexamethasone. Silencing of 11β-HSD1 increased the concentration of 11-dehydrocorticosterone in the culture supernatant but did not significantly affect the levels of corticosterone or dexamethasone. Translocation of glucocorticoid receptors to the nucleus in response to glucocorticoids was significantly attenuated by silencing 11β-HSD1. The number of cells entering the S phase of the cell cycle following the induction of adipogenesis was significantly reduced by silencing 11β-HSD1. 11β-HSD1 shRNA delivered by lentiviral vectors after the induction of differentiation, however, did not affect the progression of adipogenesis. These results indicate that 11β-HSD1 plays a significant functional role in the initiation of 3T3-L1 adipogenesis and provide new mechanistic insights into the role of 11β-HSD1 in the development of obesity and related diseases.

obesity; metabolic syndrome; glucocorticoids; cell cycle; small interfering RNA




This article has been cited by other articles:


Home page
HypertensionHome page
Z. Tian, A. S. Greene, K. Usa, I. R. Matus, J. Bauwens, J. L. Pietrusz, A. W. Cowley Jr, and M. Liang
Renal Regional Proteomes in Young Dahl Salt-Sensitive Rats
Hypertension, April 1, 2008; 51(4): 899 - 904.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.